106 related articles for article (PubMed ID: 1402063)
1. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
Fukuyama M; Oonaka K; Hara M; Imagawa Y
Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
Imagawa Y; Fukuyama M; Kawakami K; Suda O
Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Fukuyama M; Kawakami K; Suda O; Imagawa Y
Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea.
Inagaki Y; Horiuchi S; Une T; Nakaya R
J Antimicrob Chemother; 1989 Oct; 24(4):547-9. PubMed ID: 2613604
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1991 Feb; 44(2):117-29. PubMed ID: 2041153
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibilities of Escherichia coli, Salmonella and Staphylococcus aureus isolated from animals to ofloxacin and commonly used antimicrobial agents].
Takahashi I; Yoshida T; Higashide Y; Sakano T
Jpn J Antibiot; 1990 Jan; 43(1):89-99. PubMed ID: 2190017
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
[TBL] [Abstract][Full Text] [Related]
13. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A
Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
[TBL] [Abstract][Full Text] [Related]
15. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
17. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
Obana M; Matsuoka Y; Irimajiri S; Tonooka H
Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
20. The comparative in-vitro activity of ofloxacin.
Grüneberg RN; Felmingham D; O'Hare MD; Robbins MJ; Perry K; Wall RA; Ridgway GL
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
